Fig. 4.
Fig. 4. Decrease of urinary Isoprostane-F2-III (upper panel, P = .007) and Isoprostane-F2-VI (middle panel, P < .005) and plasma prothrombin fragment F1+2 (lower panel, P < .005) in patients positive for antiphospholipid antibodies after 4 weeks of combination therapy with vitamin E and vitamin C. Statistical analysis was performed by pairedt-test.

Decrease of urinary Isoprostane-F2-III (upper panel, P = .007) and Isoprostane-F2-VI (middle panel, P < .005) and plasma prothrombin fragment F1+2 (lower panel, P < .005) in patients positive for antiphospholipid antibodies after 4 weeks of combination therapy with vitamin E and vitamin C. Statistical analysis was performed by pairedt-test.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal